Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's
Go back to Lilly's (LLY) Solanezumab Phase 3 Miss is Credit-Negative Event - Moody's| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 723.55 -8.65 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $732.20 | 52 Week High | $88.16 | |||
| Open | $725.00 | 52 Week Low | $67.88 | |||
| Day High | $727.99 | P/E | 167.49 | |||
| Day Low | $718.30 | EPS | $4.32 | |||
| Volume | 1,204,171 | |||||
